Overview
Lois Ayash is an Oncologist practicing medicine in Detroit, Michigan. She has been practicing medicine for over 41 years.
Dr. Ayash is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.
She is actively involved in clinical research, co-authoring 41 peer reviewed articles and participating in 5 clinical trials. Dr. Ayash is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4100 John R St, Detroit, MI 48201
1560 E Maple Rd, Troy, MI 48083
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Henry Ford Cancer-Detroit
Shirish Gadgeel is an Oncologist practicing medicine in Detroit, Michigan. Dr. Gadgeel is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Gadgeel is currently accepting new patients.
Karmanos Cancer Center
Elisabeth Heath is an Oncologist practicing medicine in Detroit, Michigan. Dr. Heath is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Heath is currently accepting new patients.
Oncology Clinic
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology. Dr. Vaishampayan is currently accepting new patients.
Frequently Asked Questions about Dr. Lois J. Ayash
How do I make an appointment with Dr. Lois J. Ayash?
You can book an appointment with Dr. Lois J. Ayash by calling their office at 800-527-6266. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Lois J. Ayash a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lois J. Ayash is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Lois J. Ayash specialize in?
While Dr. Lois J. Ayash is a Oncology, they have specific expertise in Multiple Myeloma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Lois J. Ayash participate in research or clinical trials?
Yes. Dr. Lois J. Ayash has published 41 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Lois J. Ayash's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Lois J. Ayash accept my insurance?
Dr. Lois J. Ayash accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 800-527-6266 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Ayash isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Chronic Graft Versus Host Disease (cGvHD)Dr. Ayash isDistinguished. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Multiple MyelomaDr. Ayash isDistinguished. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Ayash isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- Angioimmunoblastic T-cell Lymphoma
- Childhood Acute Myeloid Leukemia
- Classical Hodgkin LymphomaDr. Ayash isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Hodgkin LymphomaDr. Ayash isAdvanced. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic Lymphoma
- Non-Hodgkin LymphomaDr. Ayash isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaDr. Ayash isAdvanced. Learn about Peripheral T-Cell Lymphoma.
- Smoldering Multiple MyelomaDr. Ayash isAdvanced. Learn about Smoldering Multiple Myeloma.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Ayash isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myelomonocytic LeukemiaDr. Ayash isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Anaplastic Large Cell LymphomaDr. Ayash isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- B-Cell LymphomaDr. Ayash isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Ayash isExperienced. Learn about Bone Marrow Aspiration.
- Breast CancerDr. Ayash isExperienced. Learn about Breast Cancer.
- Burkitt LymphomaDr. Ayash isExperienced. Learn about Burkitt Lymphoma.
- ChoriocarcinomaDr. Ayash isExperienced. Learn about Choriocarcinoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Ayash isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Ayash isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Dr. Ayash isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic Myelomonocytic Leukemia (CMML)
- Chronic T-Cell Leukemia (CTCL)Dr. Ayash isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Ayash isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Follicular LymphomaDr. Ayash isExperienced. Learn about Follicular Lymphoma.
- Gastric LymphomaDr. Ayash isExperienced. Learn about Gastric Lymphoma.
- Inflammatory Breast CancerDr. Ayash isExperienced. Learn about Inflammatory Breast Cancer.
- LeukemiaDr. Ayash isExperienced. Learn about Leukemia.
- Lymphofollicular HyperplasiaDr. Ayash isExperienced. Learn about Lymphofollicular Hyperplasia.
- Mantle Cell Lymphoma (MCL)Dr. Ayash isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Myeloproliferative Neoplasms (MPN)Dr. Ayash isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Philadelphia-Negative Chronic Myeloid Leukemia
- Primary Lymphoma of the BrainDr. Ayash isExperienced. Learn about Primary Lymphoma of the Brain.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Small Lymphocytic Lymphoma (SLL)Dr. Ayash isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- T-Cell LymphomaDr. Ayash isExperienced. Learn about T-Cell Lymphoma.
- Teratoma of the MediastinumDr. Ayash isExperienced. Learn about Teratoma of the Mediastinum.
- Testicular CancerDr. Ayash isExperienced. Learn about Testicular Cancer.
- Triple-Negative Breast CancerDr. Ayash isExperienced. Learn about Triple-Negative Breast Cancer.

